KALV
Price
$12.33
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
49 days until earnings call
PCVX
Price
$117.93
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
18 days until earnings call
Ad is loading...

KALV vs PCVX

Header iconKALV vs PCVX Comparison
Open Charts KALV vs PCVXBanner chart's image
KalVista Pharmaceuticals
Price$12.33
Change-$0.00 (-0.00%)
Volume$251.77K
CapitalizationN/A
Vaxcyte
Price$117.93
Change-$0.00 (-0.00%)
Volume$481.52K
CapitalizationN/A
View a ticker or compare two or three
KALV vs PCVX Comparison Chart
Loading...
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
KALV vs. PCVX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALV is a Hold and PCVX is a Buy.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (KALV: $12.33 vs. PCVX: $117.93)
Brand notoriety: KALV and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALV: 64% vs. PCVX: 47%
Market capitalization -- KALV: $500.44M vs. PCVX: $14B
KALV [@Biotechnology] is valued at $500.44M. PCVX’s [@Biotechnology] market capitalization is $14B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALV’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • KALV’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALV’s TA Score shows that 5 TA indicator(s) are bullish while PCVX’s TA Score has 3 bullish TA indicator(s).

  • KALV’s TA Score: 5 bullish, 5 bearish.
  • PCVX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, KALV is a better buy in the short-term than PCVX.

Price Growth

KALV (@Biotechnology) experienced а +9.70% price change this week, while PCVX (@Biotechnology) price change was +5.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

KALV is expected to report earnings on Dec 05, 2024.

PCVX is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($14B) has a higher market cap than KALV($500M). PCVX YTD gains are higher at: 87.787 vs. KALV (0.653). KALV has higher annual earnings (EBITDA): -131.18M vs. PCVX (-501.98M). PCVX has more cash in the bank: 1.45B vs. KALV (210M). KALV has less debt than PCVX: KALV (7.32M) vs PCVX (25.6M). KALV (0) and PCVX (0) have equivalent revenues.
KALVPCVXKALV / PCVX
Capitalization500M14B4%
EBITDA-131.18M-501.98M26%
Gain YTD0.65387.7871%
P/E RatioN/AN/A-
Revenue00-
Total Cash210M1.45B14%
Total Debt7.32M25.6M29%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KALVPCVX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 15 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with FATE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
+2.92%
FATE - KALV
42%
Loosely correlated
+5.25%
PLRX - KALV
41%
Loosely correlated
+8.00%
INZY - KALV
40%
Loosely correlated
-1.12%
SNDX - KALV
40%
Loosely correlated
+0.71%
IDYA - KALV
39%
Loosely correlated
+0.58%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+2.11%
ORKA - PCVX
62%
Loosely correlated
+4.28%
LOGC - PCVX
45%
Loosely correlated
+2.21%
PLX - PCVX
43%
Loosely correlated
+0.93%
RXRX - PCVX
42%
Loosely correlated
+5.10%
DYN - PCVX
41%
Loosely correlated
+5.39%
More